US 8580811
Androgen receptor modulator methods
granted A61PA61P1/00A61P1/02
Quick answer
US patent 8580811 (Androgen receptor modulator methods) held by Ligand Pharmaceuticals Incorporated expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P1/00, A61P1/02, A61P1/04, A61P11/00